Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer
Clinical trial NCT00477282 · COMPLETED
Trial details
- NCT number
- NCT00477282
- Sponsor
- BioNumerik Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2013-06-01
- Enrollment
- 509
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.